Chloroform → 3-(5-Cyano-2-nitrophenyl)-5-(3-cyanophenyl)isoxazole
反応式
Br[C:2]1[CH:3]=[CH:4][C:5]([N+:20]([O-:22])=[O:21])=[C:6]([C:8]2[CH:12]=[C:11]([C:13]3[CH:18]=[CH:17][CH:16]=[C:15](Br)[CH:14]=3)[O:10][N:9]=2)[CH:7]=1.[CH:23]([Cl:26])(Cl)Cl.Br[C:28]1[CH:29]=[CH:30][C:31]([O:46][CH3:47])=[C:32]([C:34]2[CH:38]=[C:37]([C:39]3[CH:44]=[CH:43][CH:42]=[C:41](Br)[CH:40]=3)[O:36][N:35]=2)[CH:33]=1.Br[C:49]1[CH:53]=[CH:52][O:51][N:50]=1>C(Cl)Cl>[C:49]([C:2]1[CH:3]=[CH:4][C:5]([N+:20]([O-:22])=[O:21])=[C:6]([C:8]2[CH:12]=[C:11]([C:13]3[CH:18]=[CH:17][CH:16]=[C:15]([C:34]#[N:35])[CH:14]=3)[O:10][N:9]=2)[CH:7]=1)#[N:50].[C:8]([C:28]1[CH:29]=[CH:30][C:31]([O:46][CH3:47])=[C:32]([C:34]2[CH:38]=[C:37]([C:39]3[CH:44]=[CH:43][CH:42]=[C:41]([C:49]#[N:50])[CH:40]=3)[O:36][N:35]=2)[CH:33]=1)#[N:9].[Cl:26][C:23]1[CH:28]=[CH:33][C:32]([C:34]#[N:35])=[CH:31][C:30]=1[C:49]1[CH:53]=[C:52]([C:3]2[CH:2]=[CH:7][C:6]([C:8]#[N:9])=[CH:5][CH:4]=2)[O:51][N:50]=1参加物
反応物 4
生成物 3
試薬・触媒・溶媒 1
実験手順
3-(5-Cyano-2-nitrophenyl)-5-(3-cyanophenyl)isoxazole (501) was prepared from bromoisoxazole 49j as light yellow crystals (0.18 g, 24%): mp 225-227° C. (CHCl3); 1H NMR δ 8.48 (s, 1H), 8.45 (s, 1H), 8.35 (m, 2H), 8.25 (d, J=7.7 Hz, 1H), 8.05 (d, J=7.7 Hz, 1H), 7.82 (t, J=7.7 Hz, 1H), 7.70 (s, 1H); HPLC (Method B) tR 6.67 min (100 area % at 265 nm). Anal. (C17H8N4O3) C, H, N. 3-(5-Cyano-2-methoxyphenyl)-5-(3-cyanophenyl)isoxazole (50m) was prepared from bromoisoxazole 49k as light yellow crystals (1.41 g, 43%): mp 241-243° C. (CH2Cl2); 1H NMR δ 8.49 (s, 1H), 8.26 (m, 2H), 8.00 (br s, 2H), 7.78 (br s, 1H), 7.68 (br s, 1H), 7.42 (s, 1H); HPLC (Method B) tR 7.36 min (97.8 area % at 265 nm). Anal. (C18H11N3O2) C, H, N. 3-(2-Chloro-5-cyanophenyl)-5-(4-cyanophenyl)isoxazole (53j) was prepared by the general method for nitriles 50 above from bromoisoxazole 53i (1.90 g, 5.28 mmol). The crude product was purified by column chromatography (CHCl3). Purified fractions were evaporated. The residue was suspended in ether and filtered off to give a pale yellow solid (0.44 g, 27%); mp 257-259° C.; 1H NMR δ 8.29 (d, J=2.1 Hz, 1H), 8.17 (d, J=8.4 Hz, 2H), 8.08 (m, 3H), 7.95 (d, J=8.4 Hz, 1H), 7.80 (s, 1H); HPLC (Method B) tR 7.55 min (92.3 area % at 265 nm). Anal. (C17H8ClN3O.0.2H2O) C, H, N.
後処理
- customThe crude product was purified by column chromatography (CHCl3)
- customPurified fractions were evaporated
- filtrationfiltered off
出典と根拠
- ORDレコード
- ord-9e9bfa9b36994bd8868e0e3740ff0e49
- 出典データセット
- uspto-grants-2011_05
- 特許番号
- US07951827B2
反応ノート
読み込み中…